Epilepsy Education
Stay up-to-date with the latest research and clinical findings on epilepsy and its treatment strategies.
Epilepsy impacts every aspect of life for patients and their loved ones. At HarmoniaMentis.se, Angelini Pharma offers a trusted platform with guidance, articles, videos, and practical information. Healthcare professionals can also access scientific resources to stay informed and support their patients.
Stay up-to-date with the latest research and clinical findings on epilepsy and its treatment strategies.
ONTOZRY® (cenobamate) is an anti-epileptic medicine used to treat focal seizures in adults.1 Discover its mechanism of action, dosing, clinical efficacy, safety profile, and drug interactions.
Enhance your skills and knowledge about epilepsy with insights and specialized training for epilepsy nurses. This educational material is designed for all nurses with interest in epilepsy.
About Epilepsy
Epilepsy is one of the most prevalent brain disorders, affecting over 50 million people worldwide.2 Defined by recurrent unprovoked seizures3, it can stem from genetic, structural, metabolic, or unknown causes.4 While antiseizure medications provide effective treatment for many, about one-third of patients face drug-resistant epilepsy.5 Accurate diagnosis and individualized care are essential to improving outcomes.5
Stay up-to-date with the latest research and clinical findings on epilepsy and its treatment strategies.
Medical Lounge
Looking for in-depth resources focused on Epilepsy and the Central Nervous System (CNS)? Step into the Medical Lounge – your hub for scientific content, educational materials, and patient support, designed exclusively for healthcare professionals.
Explore educational resources arranged by Angelini to support HCPs and the epilepsy community. Access the latest insights in epilepsy management, including focal seizures, and discover content for those unable to attend live sessions.
spacer
Contact Us
Have a question or want to connect? Find all the ways to connect with Angelini Pharma on our contact page.
Don't miss out!
Would you like to receive news, congress reports, and invitations to lectures on epilepsy and epilepsy treatments?